查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1922936

一次性塑膠血袋市場按材料類型、包裝類型、滅菌方法、容量、應用、最終用戶和銷售管道分類—全球預測（2026-2032 年）

Disposable Plastic Blood Bag Market by Material Type, Packaging Type, Sterilization Method, Capacity, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，一次性塑膠血袋市場價值將達到 30.1 億美元，到 2026 年將成長至 32.5 億美元，到 2032 年將達到 53.4 億美元，複合年成長率為 8.53%。

主要市場統計數據
基準年 2025 30.1億美元
預計年份：2026年 32.5億美元
預測年份：2032年 53.4億美元
複合年成長率 (%) 8.53%

一次性塑膠血袋是現代輸血醫學和臨床供應鏈的基礎，支持所有醫療機構的血液採集、處理和儲存。這些產品融合了材料科學、滅菌通訊協定和法規遵循性，提供一次性解決方案，保護捐血者和收件人。近年來，隨著醫療機構效率的提高、交叉感染風險的降低以及庫存管理的簡化，血袋的作用日益擴大。因此，供應商和醫療機構必須在臨床性能要求、生產實際操作和環境因素之間取得平衡。

創新路徑涵蓋了從傳統PVC共混物到新興非PVC替代品的各種材料技術，以及從單袋包裝到旨在實現組件分離的多袋包裝的各種包裝形式。滅菌方法（伽瑪射線、環氧乙烷、電子束、高壓釜）會影響產品的完整性和供應鏈的時效性。此外，醫院、診所、診斷實驗室和研究機構等終端使用者各自有著獨特的規格要求、採購週期和品質保證系統。這就要求製造商開發適應性強的平台和可擴展的製程流程，以因應不斷變化的臨床通訊協定和監管要求。

該領域近期重點工作包括提高生物相容性、確保輸血鏈全程可追溯性，以及在不影響無菌性和病人安全的前提下推動循環經濟。製造商、採購團隊和臨床治理機構之間的策略合作至關重要，以確保產品發展與醫療服務目標和永續性保持一致。

材料、滅菌技術和採購模式的變革性變化正在重新定義產品生命週期和臨床工作流程。

一次性塑膠血袋領域正經歷一系列相互交織的變革，其意義遠不止於簡單的產品改進。環境、監管和安全方面的考量正在加速材料創新，製造商正在評估非PVC替代品。這些新材料必須在柔軟性、透明度、化學相容性和低溫運輸耐久性方面達到或超過PVC的性能，同時也要與現有生產線相容。同時，滅菌技術的加工效率、殘留物分佈以及與新型聚合物的兼容性也正在重新評估，這促使人們重新審視供應鏈的進度安排和設施認證。

2025年美國關稅調整對採購、生產地點選擇及採購韌性的累積影響

2025年實施的關稅政策對一次性塑膠血袋供應鏈產生了連鎖反應，改變了採購的優先事項和計算方式。關稅調整影響了進口原料和成品組件的相對成本競爭力，促使製造商和採購機構重新評估其供應商基礎和庫存管理方式。因此，擁有多元化採購基礎和國內生產能力的公司更具韌性，而依賴單一國家供應商的公司則面臨更大的物流和合規方面的挑戰。

關鍵細分洞察揭示了應用需求、材料選擇、消毒方法和包裝形式如何共同決定臨床適用性。

對應用領域的深入分析揭示了不同的性能和設計要求。根據應用，市場可細分為血漿、血小板、紅血球和全血。在血漿中，冷沉澱、新鮮冷沉澱和血漿衍生物的要求各不相同，這會影響血袋是否適用於冷凍和分餾過程。對於血小板，單採血小板和隨機供體血小板分別需要特定的處理方法，這會影響抗凝血劑的用量、氣體滲透性和儲存方式。對於紅血球採集，諸如去除白血球、標準和洗滌等選項至關重要，而過濾器和連接設計會影響處理流程。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢正在影響監管合規、分銷和採用模式。

區域趨勢對產品適應症、監管合規性和分銷模式有顯著影響。在美洲市場，機構採購流程、嚴格的血液監測要求以及對品質保證的高度重視推動了市場的成熟，這要求供應商維護完善的文件管理和快速回應的技術支援。該地區的監管管道傾向於支持以臨床證據為支撐的漸進式創新，而供應網路則優先考慮醫院系統和大型血站的可靠性和應對力。

主要企業洞察，揭示了構成一次性血袋供應競爭優勢的能力、策略性投資和檢驗優勢。

為了維持業務永續營運，一次性血袋領域的主要企業正加大對模組化產品平台、滅菌相容性測試和供應商多元化的投資。許多領先製造商強調品管系統、合規記錄和全面的檢驗文件，以支援大型醫院和血站採用其產品。透過提供技術培訓、客製化標籤和與醫院資訊系統連接的擴展可追溯性系統等服務，企業正日益實現差異化競爭優勢。

為製造商和採購商提供切實可行的建議，以加速材料創新、保障供應鏈安全並提高永續性，同時又不影響臨床效能。

產業領導者應優先考慮平衡策略，同時推動材料創新、監管合規和供應鏈韌性。投資開發檢驗的非PVC原型，並針對各種滅菌方法實施嚴格的兼容性測試，可以降低材料相關的監管和環境壓力。同時，企業應制定正式的供應商多元化計劃，並考慮建立區域生產中心，以減輕關稅造成的成本波動和物流中斷。這種雙管齊下的方法既能提高營運柔軟性，又能維持臨床效能。

調查方法概述了為確保研究結果的可靠性和實用性而採用的多學科資料收集、檢驗和交叉檢驗程序。

本分析綜合了來自臨床相關人員、生產專家和採購人員的定性一手資訊，並輔以材料科學、滅菌技術和法規指南方面的二手文獻。一手資訊透過結構化訪談和技術諮詢收集，重點在於產品規格、滅菌相容性以及最終用戶的操作限制。二級資訊來源包括同行評審出版物、法規指南文件以及探討聚合物性能和血液監測最佳實踐的行業技術論文。

結論：對不斷變化的一次性血袋市場中相關人員的關鍵策略要務、新興風險和機會領域進行綜合分析

結論總結了相關人員在應對一次性塑膠血袋市場時需要考慮的策略要務、新興風險和優先行動。

一次性塑膠血袋產業正處於轉折點，材料創新、滅菌驗證、不斷演變的採購方式以及地緣政治因素共同交織，重塑競爭格局。相關人員必須在確保臨床性能和安全性的同時，應對改善環境績效和控制檢驗帶來的成本風險。投資於經驗證的非PVC替代品、實現生產和採購管道多元化並加強與臨床終端用戶合作的企業，將更有能力應對監管變化和供應鏈波動。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 銷售管道分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章 美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

8. 一次性塑膠血袋市場（依材料類型分類）

  • 不含聚氯乙烯
  • PVC

9. 一次性塑膠血袋市場（依包裝類型分類）

  • 雙層袋
  • 衛星套件
  • 米包

第10章 依滅菌方法分類的一次性塑膠血袋市場

  • 高壓釜
  • 電子束
  • 環氧乙烷
  • 伽瑪射線

第11章 一次性塑膠血袋市場（以銷售量計）

  • 250～500ml
  • 500毫升或以上
  • 250毫升或以下

第12章：一次性塑膠血袋市場（按應用領域分類）

  • 電漿
    • 冷沉澱物
    • 新鮮冷沉澱物
    • 血漿製品
  • 血小板
    • 血小板分離術
    • 隨機供體血小板
  • 紅血球
    • 白血球去除
    • 標準
    • 洗過的血
  • 全血

第13章 一次性塑膠血袋市場（依最終用戶分類）

  • 診所
  • 診斷實驗室
  • 醫院
  • 研究所

第14章 一次性塑膠血袋市場（依銷售管道分類）

  • 直銷
  • 批發商

第15章 各地區一次性塑膠血袋市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 一次性塑膠血袋市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 各國一次性塑膠血袋市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國一次性塑膠血袋市場

第17章：中國一次性塑膠血袋市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AdvaCare Pharma, Inc.
  • B. Braun Melsungen SE
  • Baxter International Inc.
  • Beijing Bode Sangte Blood Equipment Technology Development Center
  • Fresenius Kabi AG
  • GenesisBPS
  • Grifols, SA
  • Haemonetics Corporation
  • HLL Lifecare Limited
  • Innvol Medical India Ltd.
  • JMS Co., Ltd.
  • Macopharma SA
  • Ningbo David Medical Device Co., Ltd.
  • Nipro Corporation
  • Poly Medicure Limited
  • SB-Kawasumi Laboratories Inc.
  • Shandong Yimei Medical Technology Co., Ltd.
  • Shanghai Transfusion Technology Co., Ltd.
  • Sichuan Mianzhu Hongji Pharmaceutical Co., Ltd.
  • SURU International Pvt. Ltd.
  • Terumo Corporation
  • Wego Holding Co., Ltd.
  • Zhengzhou Feilong Medical Equipment Co., Ltd.
Product Code: MRR-867BED9A9E6A

The Disposable Plastic Blood Bag Market was valued at USD 3.01 billion in 2025 and is projected to grow to USD 3.25 billion in 2026, with a CAGR of 8.53%, reaching USD 5.34 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.01 billion
Estimated Year [2026] USD 3.25 billion
Forecast Year [2032] USD 5.34 billion
CAGR (%) 8.53%

Disposable plastic blood bags remain a cornerstone of modern transfusion medicine and clinical supply chains, underpinning blood collection, processing, and storage across care settings. These products combine material science, sterilization protocols, and regulatory compliance to deliver single-use solutions that protect both donors and recipients. Recently, their role has broadened as facilities pursue efficiency gains, lower cross-contamination risk, and more streamlined inventory practices. Consequently, suppliers and healthcare providers must reconcile clinical performance requirements with manufacturing practicability and environmental stewardship.

The innovation trajectory spans materials such as traditional PVC blends and emerging non-PVC alternatives, alongside packaging configurations ranging from single to multi-bag systems tailored for component separation. Sterilization choices-gamma, ethylene oxide, electron beam, and autoclave-impact both product integrity and supply chain timing. Moreover, end users including hospitals, clinics, diagnostic laboratories, and research institutes each impose distinct specifications, procurement cycles, and quality assurances. As a result, producers must develop adaptable platforms and scalable processes that respond to shifting clinical protocols and regulatory scrutiny.

Moving forward, the sector's near-term priorities include enhancing biocompatibility, ensuring traceability across transfusion chains, and addressing circularity concerns without compromising sterility or patient safety. Strategic collaboration across manufacturers, procurement teams, and clinical governance bodies will be essential to align product evolution with healthcare delivery objectives and sustainability commitments.

Transformative shifts in materials, sterilization technologies, and procurement models that are redefining product lifecycles and clinical workflows

The disposable plastic blood bag landscape is undergoing a series of convergent shifts that extend beyond incremental product improvements. Material innovation is accelerating as manufacturers evaluate non-PVC alternatives to address environmental, regulatory, and safety considerations. These materials must replicate or exceed PVC's performance in flexibility, clarity, chemical compatibility, and cold chain resilience, while also fitting established processing lines. At the same time, sterilization technologies are being reassessed for throughput efficiency, residue profiles, and compatibility with new polymers, prompting reevaluation of supply chain timing and facility certifications.

In parallel, procurement models are transforming. Hospitals and large clinical networks increasingly demand integrated supply agreements, data-driven vendor selection, and lifecycle transparency. This shift is accompanied by a growing emphasis on traceability and batch-level documentation to support hemovigilance and regulatory audits. Moreover, packaging strategies are adapting to component-specific workflows: multi-bag configurations and satellite systems are being optimized for automated fractionation and bedside transfusion. Consequently, manufacturers are prioritizing modular product families that support various collection protocols and component separation needs.

Taken together, these changes are driving a competitive landscape where compliance, adaptability, and sustainability are as crucial as cost and availability. Strategic investments in material R&D, sterilization validation, and supply chain digitization will determine which suppliers can meet evolving clinical requirements while maintaining operational resilience.

Cumulative implications of the United States tariff adjustments in 2025 on sourcing, production location decisions, and procurement resilience

The tariff environment introduced in 2025 has had cascading effects across the disposable plastic blood bag supply chain, altering sourcing priorities and procurement calculus. Tariff adjustments have influenced the relative cost competitiveness of imported raw materials and finished components, prompting manufacturers and purchasing organizations to reassess supplier bases and inventory policies. As a result, firms with diversified sourcing footprints or domestic manufacturing capabilities have experienced improved resilience, while those reliant on single-country suppliers faced elevated logistics and compliance friction.

In response to the tariff measures, several stakeholders accelerated nearshoring and supplier qualification processes to reduce exposure to cross-border duty volatility. This shift has had implications for lead times, capacity planning, and supplier development investments. Additionally, tariff-driven cost pressures intensified conversations around material substitution and design optimization to maintain price competitiveness without compromising clinical performance. Procurement teams have therefore become more engaged in technical evaluation and total cost of ownership discussions, integrating duties, transportation, and quality assurance into supplier scorecards.

Looking forward, the tariff landscape has emphasized the strategic value of flexible supply chains and contractual mechanisms that mitigate duty risk. Collaborative planning between manufacturers and large end users, together with investments in domestic or regional production nodes, will help stabilize availability and manage price exposure. Ultimately, the cumulative impact of the 2025 tariff changes underscores the need for strategic agility and scenario planning across the disposable blood bag ecosystem.

Key segmentation insights revealing how application needs, material choices, sanitization methods, and packaging formats jointly determine clinical suitability

A deep view across application segments shows distinct performance and design imperatives. Based on Application the market is assessed across Plasma, Platelets, Red Blood Cells, and Whole Blood, and within Plasma there are differentiated requirements for Cryoprecipitate, Fresh Frozen Plasma, and Plasma Derivatives that affect bag compatibility with freezing and fractionation processes. Platelets demand specific handling for Apheresis Platelets and Random Donor Platelets, each with implications for anticoagulant volumes, gas permeability, and storage ergonomics. Red Blood Cells collections emphasize options such as Leukoreduced, Standard, and Washed variants where filter and connection design influence processing workflows.

Material choice remains a pivotal driver of manufacturing and clinical performance. Based on Material Type the market is evaluated across non-PVC and PVC substrates, with non-PVC variants increasingly considered for their potential to reduce plasticizer-related concerns and improve recyclability, while PVC continues to offer proven flexibility and cold-chain reliability. End user requirements further refine product specifications. Based on End User the market spans Clinics, Diagnostic Laboratories, Hospitals, and Research Institutes, each imposing distinct procurement cadences, sterility expectations, and regulatory interactions that influence minimum order quantities and packaging preferences.

Packaging type and sterilization methodology also dictate design trade-offs. Based on Packaging Type options include Double Bag, Satellite Bag, and Triple Bag configurations that support various component separation strategies and bedside procedures, while sterilization choices based on Autoclave, Electron Beam, Ethylene Oxide, and Gamma methods impose material compatibility constraints and validation obligations. Capacity considerations based on 250-500 ml, Above 500 ml, and Less Than 250 ml sizes affect manufacturing tooling, storage efficiency, and clinical suitability. Finally, sales channel dynamics based on Direct Sales and Distributors determine who drives product specification decisions and after-sales support, shaping how suppliers allocate commercial resources and technical services.

Region-specific dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape regulatory compliance, distribution, and adoption patterns

Regional dynamics materially influence product adaptation, regulatory compliance, and distribution models. In the Americas market sophistication is often driven by institutional procurement processes, stringent hemovigilance requirements, and a strong emphasis on quality assurance, prompting suppliers to maintain robust documentation and rapid technical support. Regulatory pathways in this region can favor incremental innovation when supported by clinical evidence, and supply networks tend to prioritize reliability and responsiveness for hospital systems and large blood centers.

Across Europe, Middle East & Africa the landscape varies considerably, with certain countries emphasizing sustainability mandates and non-PVC alternatives, while others focus on cost containment and local manufacturing incentives. These differences drive a need for modular product families and flexible sterilization validation packages to meet divergent national regulations and procurement frameworks. In the Asia-Pacific region demand growth is influenced by expanding healthcare infrastructure, rising blood banking capacity, and an increasing adoption of component-based transfusion practices. Consequently, suppliers targeting this region benefit from scalable manufacturing models, regional distribution hubs, and training programs tailored to variable clinical protocols.

Taken together, these regional contrasts necessitate differentiated go-to-market strategies that account for regulatory approvals, sterilization certifications, and logistical realities. Manufacturers and distributors should therefore align product portfolios and service offerings with the dominant procurement logic and clinical priorities of each region to optimize market penetration and long-term relationships.

Key company insights into how capabilities, strategic investments, and validation strengths determine competitive advantage in disposable blood bag supply

Leading companies in the disposable blood bag space are investing in modular product platforms, sterilization compatibility testing, and supplier diversification to maintain operational continuity. Many top-tier manufacturers emphasize quality management systems, regulatory track records, and comprehensive validation documentation to support adoption by large hospitals and blood centers. Competitive differentiation is increasingly achieved through service offerings such as technical training, customized labelling, and extended traceability systems that integrate with hospital information systems.

Capability gaps are apparent among smaller suppliers that may offer competitive pricing but lack validated sterilization pathways or comprehensive post-market surveillance programs. These gaps create opportunities for strategic partnerships, contract manufacturing arrangements, and technology licensing deals. In addition, the shift toward non-PVC materials and multi-bag configurations presents both a challenge and an opportunity: companies that successfully validate novel polymers and demonstrate long-term stability under cryogenic and refrigeration conditions will gain preferential access to quality-sensitive accounts.

Strategic imperatives for market participants include reinforcing regulatory affairs teams, accelerating material science collaborations, and expanding regional manufacturing or distribution footprints to mitigate tariff and logistics risks. Firms that combine technical excellence with flexible commercial models will be best positioned to capture the shifting demand for clinically robust, sustainable, and compliant disposable blood collection systems.

Actionable recommendations for manufacturers and buyers to accelerate material innovation, secure supply chains, and enhance sustainability without compromising clinical performance

Industry leaders should prioritize a balanced strategy that concurrently addresses material innovation, regulatory preparedness, and supply chain resilience. Investing in validated non-PVC prototypes and conducting robust compatibility testing across sterilization methods will reduce exposure to material-specific regulatory or environmental pressures. At the same time, companies should formalize supplier diversification plans and consider regional production nodes to mitigate tariff-induced cost volatility and logistics disruptions. This dual-track approach preserves clinical performance while improving operational flexibility.

Commercially, forging closer partnerships with large hospital systems and blood service organizations will enable co-development of product variants tailored to specific component separation workflows and storage protocols. Enhancing digital traceability and batch-level documentation will support hemovigilance needs and simplify audit processes for procurement teams. In addition, embedding sustainability metrics into product development-such as designing for reduced material usage, recyclability, or take-back programs-can improve brand positioning without compromising sterility or safety.

Finally, organizations should adopt scenario planning and cross-functional governance to rapidly respond to regulatory or tariff changes. Prioritizing investments that simultaneously bolster clinical performance, reduce environmental footprint, and strengthen supply chain redundancy will provide the most durable competitive advantage in a market characterized by evolving clinical expectations and policy dynamics.

Research methodology outlining the multidisciplinary data collection, validation, and cross-verification steps employed to ensure robust and actionable insights

The analysis synthesized primary qualitative inputs from clinical stakeholders, manufacturing experts, and procurement leaders, complemented by secondary literature on materials science, sterilization technologies, and regulatory guidance. Primary inputs were gathered through structured interviews and technical consultations that focused on product specifications, sterilization compatibility, and operational constraints across end users. Secondary sources included peer-reviewed publications, regulatory agency guidance documents, and trade-focused technical papers addressing polymer performance and hemovigilance best practices.

Analytical rigor was maintained through cross-validation of findings across multiple data streams, triangulating clinical requirements with manufacturing feasibility and distribution realities. Validation steps included technical reviews of sterilization compatibility matrices, material stability assessments under cold chain conditions, and consultation with subject matter experts in blood bank operations. Where divergent perspectives emerged, results were reconciled through additional targeted interviews and scenario testing to ensure conclusions reflected practical constraints and stakeholder priorities.

Finally, the research prioritized transparency in assumptions and methodological limitations, documenting validation activities and highlighting areas where further empirical testing or longitudinal surveillance would strengthen confidence. This methodology ensures that insights are grounded in real-world practice while remaining actionable for decision-makers.

Conclusion synthesizing the core strategic imperatives, emergent risks, and opportunity areas for stakeholders in the evolving disposable blood bag market

Conclusion synthesizing strategic imperatives, emergent risks, and priority actions for stakeholders navigating the disposable plastic blood bag landscape

The disposable plastic blood bag sector is at an inflection point where material innovation, sterilization validation, procurement evolution, and geopolitical factors jointly determine competitive outcomes. Stakeholders must reconcile clinical performance and safety with pressures to improve environmental profiles and manage tariff-driven cost exposures. Those organizations that invest in validated non-PVC alternatives, diversify manufacturing and sourcing, and deepen partnerships with clinical end users will be better placed to weather regulatory shifts and supply chain volatility.

Emergent risks include material compatibility challenges under different sterilization regimes, supply disruptions arising from concentrated sourcing, and increasing scrutiny on lifecycle impacts. Conversely, opportunities arise from designing product families that cater to specific component workflows, leveraging traceability and data integration to enhance hemovigilance, and adopting sustainability measures that resonate with procurement criteria. Prioritizing these strategic actions will enable manufacturers and buyers to align clinical efficacy with operational resilience and long-term market relevance.

In summary, a proactive, multidisciplinary approach that integrates material science, regulatory strategy, and supply chain planning will be essential for stakeholders seeking to lead in this evolving landscape. Focused investments and collaborative partnerships will translate insights into tangible improvements across product performance, compliance, and environmental stewardship.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Disposable Plastic Blood Bag Market, by Material Type

  • 8.1. Non-Pvc
  • 8.2. Pvc

9. Disposable Plastic Blood Bag Market, by Packaging Type

  • 9.1. Double Bag
  • 9.2. Satellite Bag
  • 9.3. Triple Bag

10. Disposable Plastic Blood Bag Market, by Sterilization Method

  • 10.1. Autoclave
  • 10.2. Electron Beam
  • 10.3. Ethylene Oxide
  • 10.4. Gamma

11. Disposable Plastic Blood Bag Market, by Capacity

  • 11.1. 250-500 Ml
  • 11.2. Above 500 Ml
  • 11.3. Less Than 250 Ml

12. Disposable Plastic Blood Bag Market, by Application

  • 12.1. Plasma
    • 12.1.1. Cryoprecipitate
    • 12.1.2. Fresh Frozen Plasma
    • 12.1.3. Plasma Derivatives
  • 12.2. Platelets
    • 12.2.1. Apheresis Platelets
    • 12.2.2. Random Donor Platelets
  • 12.3. Red Blood Cells
    • 12.3.1. Leukoreduced
    • 12.3.2. Standard
    • 12.3.3. Washed
  • 12.4. Whole Blood

13. Disposable Plastic Blood Bag Market, by End User

  • 13.1. Clinics
  • 13.2. Diagnostic Laboratories
  • 13.3. Hospitals
  • 13.4. Research Institutes

14. Disposable Plastic Blood Bag Market, by Sales Channel

  • 14.1. Direct Sales
  • 14.2. Distributors

15. Disposable Plastic Blood Bag Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Disposable Plastic Blood Bag Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Disposable Plastic Blood Bag Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Disposable Plastic Blood Bag Market

19. China Disposable Plastic Blood Bag Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. AdvaCare Pharma, Inc.
  • 20.6. B. Braun Melsungen SE
  • 20.7. Baxter International Inc.
  • 20.8. Beijing Bode Sangte Blood Equipment Technology Development Center
  • 20.9. Fresenius Kabi AG
  • 20.10. GenesisBPS
  • 20.11. Grifols, S.A.
  • 20.12. Haemonetics Corporation
  • 20.13. HLL Lifecare Limited
  • 20.14. Innvol Medical India Ltd.
  • 20.15. JMS Co., Ltd.
  • 20.16. Macopharma S.A.
  • 20.17. Ningbo David Medical Device Co., Ltd.
  • 20.18. Nipro Corporation
  • 20.19. Poly Medicure Limited
  • 20.20. SB-Kawasumi Laboratories Inc.
  • 20.21. Shandong Yimei Medical Technology Co., Ltd.
  • 20.22. Shanghai Transfusion Technology Co., Ltd.
  • 20.23. Sichuan Mianzhu Hongji Pharmaceutical Co., Ltd.
  • 20.24. SURU International Pvt. Ltd.
  • 20.25. Terumo Corporation
  • 20.26. Wego Holding Co., Ltd.
  • 20.27. Zhengzhou Feilong Medical Equipment Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DOUBLE BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DOUBLE BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DOUBLE BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SATELLITE BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SATELLITE BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SATELLITE BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY TRIPLE BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY TRIPLE BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY TRIPLE BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY AUTOCLAVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY AUTOCLAVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY AUTOCLAVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY ELECTRON BEAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY ELECTRON BEAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY ELECTRON BEAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY ETHYLENE OXIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY ETHYLENE OXIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY GAMMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY GAMMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY GAMMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY 250-500 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY 250-500 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY 250-500 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY ABOVE 500 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY ABOVE 500 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY ABOVE 500 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY LESS THAN 250 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY LESS THAN 250 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY LESS THAN 250 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CRYOPRECIPITATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CRYOPRECIPITATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY FRESH FROZEN PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY FRESH FROZEN PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY FRESH FROZEN PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA DERIVATIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA DERIVATIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA DERIVATIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APHERESIS PLATELETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APHERESIS PLATELETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APHERESIS PLATELETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RANDOM DONOR PLATELETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RANDOM DONOR PLATELETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RANDOM DONOR PLATELETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY LEUKOREDUCED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY LEUKOREDUCED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY LEUKOREDUCED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STANDARD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STANDARD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STANDARD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY WASHED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY WASHED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY WASHED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 203. GCC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. GCC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. GCC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 207. GCC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 208. GCC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. GCC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 210. GCC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 211. GCC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 212. GCC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. GCC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 236. G7 DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. G7 DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. G7 DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. G7 DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 240. G7 DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 241. G7 DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. G7 DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 243. G7 DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 244. G7 DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 245. G7 DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. G7 DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 247. NATO DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. NATO DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. NATO DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. NATO DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 251. NATO DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 252. NATO DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. NATO DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 254. NATO DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 255. NATO DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 256. NATO DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. NATO DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)